The 7th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2014), 5-8 February 2014, Vienna, Austria

Advancing Towards the Next Frontier in Glucose Monitoring: 14-day, no-calibration sensors and AGP

You are cordially invited to an Abbott sponsored symposium on the occasion of the 7th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD).

Wednesday 5th February 2014, 16:45–18:15
Hall III, Messe Wien Congress Centre, Vienna

Chair: Professor Emanuele Bosi, Milan, Italy


1. Introduction

Professor Emanuele Bosi

Vita-Salute San Raffaele University, Milan, Italy

Emanuele Bosi is Associate Professor of Endocrinology at the Vita-Salute San Raffaele University, Director of the Diabetes Research Institute and the Department of Internal Medicine at the San Raffaele Hospital Scientific Institute, Milan, Italy.

Emanuele Bosi graduated in Medicine in 1979 from the University of Milan, Italy, where he also received a specialty diploma in diabetes and metabolic diseases and subsequently in clinical immunology. During his career he has received clinical training in Milan and worked as a clinical investigator at the Edouard Herriot Hospital in Lyon, France, and University College and St Bartholomew’s Hospitals in London, UK.

Professor Bosi’s research activity has been entirely devoted to diabetes. He is a leader in clinical investigations and clinical trials on both type 1 and type 2 diabetes and diabetic complications. He has published over 150 scientific papers.


2. Value of AGP in clinical practice: A retrospective review

Professor David Kerr

Bournemouth Diabetes and Endocrine Centre, Bournemouth, UK

Professor David Kerr MD FRCPE is Consultant Physican at the Bournemouth Diabetes and Endocrine Centre. He is also Honorary Senior Lecturer at the University of Southampton and Visiting Professor at Bournemouth University. He also holds a Gold Clinical Excellence Award from the UK National Health Service.

As well as providing clinical service, Professor Kerr is Editor of Diabetes Digest and Co-Founder of the UK Diabetes National In-patient Network. He has also created and launched a free on-line resource dedicated to travel and diabetes ( and another ( focusing on exercise and insulin. He has launched a smartphone application for patients with painful neuropathy. Currently he is working with the Diabetes Technology Society to create a Certification Program for Health Care Professionals in the area of diabetes and technology.

Professor Kerr’s profile can be found at: You can also follow him on Twitter: @GoDiabetesMD


3. Value of AGP in T2 diabetes

Dr Michael Joubert

Caen University Hospital, Caen, France

Dr Michael Joubert, MD, is a senior endocrinologist in the diabetes care unit of Caen University Hospital. He is Vice-President of the scientific committee for the delegation of clinical research and innovation of Caen University Hospital.

His areas of interest and research topics include development of innovative technologies such as insulin pumps, CGM, telemedicine, new drugs and therapeutic devices, especially for patients with type 2 diabetes (T2D). He also designs and develops serious games for diabetes therapeutic education.

He has participated in several academic and industry clinical trials in the above mentioned areas and is the author of a review about the use of CGM in clinical practice.


4. A 14-day glucose sensor with no user calibration

Udo Hoss

Abbott Diabetes Care, Alameda, US

Udo Hoss is the Director of Sensor Chemistry in the Research and Development group of Abbott Diabetes Care (ADC). He is responsible for the development of next generation sensors, with a special focus on the underlying chemistry.

Udo has been involved in the development of biosensor technology for more than 20 years. He studied Physics at the University of Konstanz, Germany, and earned his doctorate degree in Human Biology (Ulm, Germany). In 2010 he obtained a Biodesign Graduate Certificate from Stanford University. Udo has held several research and management positions in industry as well as academic research institutions.

Udo has been in his current role with Abbott Diabetes Care since 2005. The goal of his work is to develop sensor technologies which allow for more accurate and convenient glucose monitoring. He is the inventor of numerous patents and has published his work at international conferences and in peer reviewed scientific journals.


5. Flash Glucose Monitoring

Jared Watkin

Abbott Diabetes Care, Alameda, US

Jared Watkin is Divisional Vice President of Technical Operations for Abbott Diabetes Care (ADC) and is responsible for ADC’s Global Research & Development, Clinical Affairs and Scientific Affairs activities.

Jared has worked in the diabetes field for almost 25 years, since joining MediSense, later acquired by Abbott, in 1989. Over that time, he has been involved in the development of numerous monitoring products, including the world’s first biosensor test strip for home monitoring of ketones (β-hydroxybutyrate), and the chemistry scheme that still forms the basis of all ADC’s Precision/Optium branded glucose test strips. Jared has been actively involved in sensor-based product development since 2004, following Abbott’s acquisition of TheraSense, and was responsible for the development of the Freestyle Navigator Continuous Glucose Monitoring System product range. He was appointed to his current role in 2010.